Phase I BP Interferon (IFN) Beta-004

NCT02517788 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Interferon beta-1a HSA-free biosimilar
DRUG: Interferon beta-1a HSA+ biosimilar
DRUG: Interferon beta-1a original

Sponsor

Centre Hospitalier Universitaire Vaudois

Collaborators

[object Object]